Sotera Health Company (SHC)
USD 12.38
(2.31%)
USD 12.38
(2.31%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 276.69 Million USD | 43.54% |
| 2022 | 248.35 Million USD | -3.27% |
| 2021 | 256.73 Million USD | 24.62% |
| 2020 | 206.01 Million USD | 12.21% |
| 2019 | 183.59 Million USD | 127.09% |
| 2018 | 80.84 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 85.21 Million USD | 43.05% |
| 2024 Q3 | 80.5 Million USD | -5.52% |
| 2024 Q1 | 59.56 Million USD | -52.21% |
| 2023 Q3 | 76.09 Million USD | 20.4% |
| 2023 FY | 356.47 Million USD | 43.54% |
| 2023 Q4 | 124.63 Million USD | 63.79% |
| 2023 Q1 | 33.36 Million USD | -44.55% |
| 2023 Q2 | 63.2 Million USD | 89.43% |
| 2022 Q4 | 60.16 Million USD | -4.79% |
| 2022 FY | 248.35 Million USD | -3.27% |
| 2022 Q1 | 53.49 Million USD | -19.47% |
| 2022 Q3 | 63.19 Million USD | -11.61% |
| 2022 Q2 | 71.49 Million USD | 33.66% |
| 2021 Q1 | 46.36 Million USD | -11.49% |
| 2021 FY | 256.73 Million USD | 24.62% |
| 2021 Q4 | 66.42 Million USD | 1.15% |
| 2021 Q3 | 65.67 Million USD | -16.1% |
| 2021 Q2 | 78.27 Million USD | 68.82% |
| 2020 Q4 | 52.38 Million USD | 11.38% |
| 2020 Q3 | 47.03 Million USD | -23.83% |
| 2020 Q2 | 61.74 Million USD | 37.62% |
| 2020 Q1 | 44.86 Million USD | -1.33% |
| 2020 FY | 206.01 Million USD | 12.21% |
| 2019 Q3 | 35.56 Million USD | -32.09% |
| 2019 FY | 183.59 Million USD | 127.09% |
| 2019 Q1 | 52.37 Million USD | 0.0% |
| 2019 Q2 | 52.37 Million USD | 0.0% |
| 2019 Q4 | 45.47 Million USD | 27.84% |
| 2018 FY | 80.84 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | 384.203% |
| Biodesix, Inc. | -41.34 Million USD | 769.276% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | 3570.263% |
| Castle Biosciences, Inc. | -67.97 Million USD | 507.038% |
| DarioHealth Corp. | -56.18 Million USD | 592.431% |
| Exact Sciences Corporation | -215.01 Million USD | 228.687% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 74.78% |
| Illumina, Inc. | -1.06 Billion USD | 125.883% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | 2790.726% |
| iSpecimen Inc. | -11.16 Million USD | 2577.244% |
| Standard BioTools Inc. | -76.6 Million USD | 461.217% |
| 23andMe Holding Co. | -321.35 Million USD | 186.101% |
| Medpace Holdings, Inc. | 336.82 Million USD | 17.853% |
| NeoGenomics, Inc. | -107.73 Million USD | 356.824% |
| Inotiv, Inc. | -81.46 Million USD | 439.666% |
| Psychemedics Corporation | -2.92 Million USD | 9572.509% |
| Prenetics Global Limited | -52.51 Million USD | 626.896% |
| Precipio, Inc. | -7.62 Million USD | 3731.129% |
| RadNet, Inc. | 98.69 Million USD | -180.345% |
| Star Equity Holdings, Inc. | -4.34 Million USD | 6466.59% |
| Exagen Inc. | -22.83 Million USD | 1311.595% |
| Natera, Inc. | -446.24 Million USD | 162.005% |
| Aspira Women's Health Inc. | -18.85 Million USD | 1567.706% |
| Neogen Corporation | 58.66 Million USD | -371.664% |
| Myriad Genetics, Inc. | -123.7 Million USD | 323.68% |
| ICON Public Limited Company | 956.15 Million USD | 71.062% |
| Bionano Genomics, Inc. | -215.24 Million USD | 228.547% |
| CareDx, Inc | -101.9 Million USD | 371.533% |
| Check-Cap Ltd. | -19.28 Million USD | 1534.604% |
| Twist Bioscience Corporation | -220.83 Million USD | 225.296% |
| Guardant Health, Inc. | -564.72 Million USD | 148.996% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | 10768.31% |
| Fulgent Genetics, Inc. | -72.69 Million USD | 480.62% |
| Sera Prognostics, Inc. | -39.82 Million USD | 794.839% |
| OPKO Health, Inc. | -157.02 Million USD | 276.213% |
| Personalis, Inc. | -109.93 Million USD | 351.685% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | 2626.109% |
| Star Equity Holdings, Inc. | -4.34 Million USD | 6466.59% |
| MDxHealth SA | -27.32 Million USD | 1112.522% |
| Prenetics Global Limited | -52.51 Million USD | 626.896% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | 2729.968% |
| Mainz Biomed B.V. | -26.64 Million USD | 1138.451% |
| Trinity Biotech plc | -27.04 Million USD | 1123.08% |
| Neuronetics, Inc. | -30.55 Million USD | 1005.584% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | 3570.263% |